Leukocytosis

Background

• Leukocytosis is defined as a WBC count > 11,000 cells/μL in adults
• Hyperleukocytosis is defined as WBC > 100,000 cells/μL and is a hematologic emergency
• Leukemoid reaction refers to WBC 50,000–100,000 cells/μL from a reactive (non-malignant) cause
• The WBC count can double within hours from stress demargination (surgery, trauma, exercise, seizures, emotional stress)
• Classification is based on which cell line is predominantly elevated:
  • Neutrophilia (> 7,700/μL) — most common; typically infection, inflammation, or stress
  • Lymphocytosis (> 4,800/μL) — viral infections, CLL
  • Monocytosis (> 800/μL) — chronic infections, autoimmune disease, malignancy
  • Eosinophilia (> 500/μL) — allergic, parasitic, drug reactions, malignancy
  • Basophilia (> 100/μL) — myeloproliferative neoplasms (especially CML)
• Always interpret the absolute cell count (total WBC × differential percentage), not the relative percentage alone
• Age-specific considerations:
  • Neonates: normal WBC up to 30,000/μL at birth; shifts toward lymphocyte predominance in early childhood
  • Pregnancy: normal WBC up to ~13,000–15,000/μL in third trimester; leukocytosis is unreliable for diagnosing infection in the postpartum period

Clinical Features

• Leukocytosis itself is a laboratory finding, not a disease — clinical features depend on the underlying cause
• May be an incidental finding or occur in the context of:
  • Fever, chills, localizing signs of infection
  • Malaise, fatigue, weight loss, night sweats, bruising (concerning for malignancy)
  • Abdominal pain (appendicitis, cholecystitis, diverticulitis, abscess)
  • Chest pain, dyspnea, cough (pneumonia, PE, ACS)
  • Trauma, burns, post-surgical state
  • Medication changes (corticosteroids, lithium, epinephrine, beta-agonists)
• Red flags for malignant etiology:
  • Unexplained constitutional symptoms (B symptoms: fever, night sweats, weight loss > 10%)
  • Hepatosplenomegaly or diffuse lymphadenopathy
  • Petechiae, ecchymoses, or mucosal bleeding (concurrent thrombocytopenia)
  • WBC > 50,000/μL without clear reactive cause
  • Blasts on peripheral smear
• Red flags for leukostasis (WBC > 100,000):
  • Dyspnea, hypoxia (pulmonary leukostasis — worst prognostic sign)
  • Altered mental status, headache, visual changes, focal deficits (CNS leukostasis)
  • Priapism
  • Signs of tumor lysis syndrome or DIC

Differential Diagnosis

Leukocytosis

• Normally responding bone marrow
  • Infection
  • Inflammation: tissue necrosis, infarction, burns, arthritis
  • Stress: overexertion, seizures, anxiety, anesthesia
  • Drugs: corticosteroids, lithium, beta agonists
  • Trauma: splenectomy
  • Hemolytic anemia
  • Leukemoid malignancy
• Abnormal bone marrow
  • Acute leukemia
    • Acute myeloid leukemia
    • Acute lymphocytic leukemia
  • Chronic leukemia
    • Chronic myeloid leukemia
  • Myeloproliferative disorders

By Cell Type

Neutrophilia (Most Common)

• Infection: Bacterial (most common overall), fungal
• Inflammation: Pancreatitis, inflammatory bowel disease, vasculitis, gout, rheumatologic disorders
• Stress/physiologic: Surgery, trauma, exercise, seizures, pain, emotional stress, labor
• Medications: Corticosteroids (causes demargination; WBC can rise 2,000–5,000/μL within hours), lithium, epinephrine, beta-agonists, G-CSF/GM-CSF
• Tissue necrosis: MI, burns, crush injury, ischemic bowel
• Smoking (chronic mild neutrophilia)
• Asplenia/post-splenectomy
• Malignancy: CML, other myeloproliferative neoplasms, solid tumors (paraneoplastic)
• Leukemoid reaction: Severe infection (C. difficile, tuberculosis), hemorrhage, ethylene glycol poisoning

Lymphocytosis

• Viral infections: EBV (mononucleosis), CMV, hepatitis, HIV (acute), pertussis, influenza
• Malignancy: CLL (most common cause in adults > 50), ALL, lymphoma
• Other: Hyperthyroidism, adrenal insufficiency, autoimmune disease, post-splenectomy
• Reactive lymphocytosis can reach 20,000–30,000/μL; atypical lymphocytes on smear suggest viral etiology

Monocytosis

• Chronic infections (tuberculosis, endocarditis, brucellosis)
• Autoimmune/inflammatory disease (SLE, sarcoidosis, IBD)
• Malignancy (CMML, Hodgkin lymphoma)
• Recovery phase of acute infection or neutropenia

Eosinophilia

• See main article: Eosinophilia
• Allergic disease (asthma, atopic dermatitis, allergic rhinitis)
• Parasitic infections (especially tissue-invasive helminths)
• Drug reactions (DRESS syndrome, other drug hypersensitivity)
• Malignancy (Hodgkin lymphoma, hypereosinophilic syndrome)
• Adrenal insufficiency

Basophilia

• Myeloproliferative neoplasms (CML — basophilia is an important clue)
• Allergic/inflammatory conditions (rarely elevates basophils above threshold alone)

Evaluation

Initial Workup

• CBC with differential — determine which cell line is elevated; calculate absolute counts
• Peripheral smear — essential if:
  • WBC > 25,000–30,000/μL without clear reactive cause
  • Concern for malignancy (blasts, left shift, atypical cells)
  • Concurrent cytopenias (anemia, thrombocytopenia)
  • Evaluate for blasts (leukemia), atypical lymphocytes (viral), left shift (severe infection), leukoerythroblastic picture (marrow infiltration)
• BMP/CMP — electrolytes (pseudohyperkalemia can occur with extreme leukocytosis due to lysis in the tube), renal function, glucose, LDH, uric acid
• Blood cultures — if febrile, hemodynamically unstable, or concern for bacteremia/sepsis
• Urinalysis — if urinary source suspected
• CXR — if respiratory symptoms or concern for pneumonia
• Lactate — if concern for sepsis or tissue hypoperfusion

Directed Workup Based on Clinical Scenario

• Suspected infection: Appropriate cultures, imaging, inflammatory markers (CRP, procalcitonin)
• Suspected malignancy (blasts on smear, unexplained extreme leukocytosis):
  • Emergent hematology consultation
  • Flow cytometry (for immunophenotyping)
  • LDH, uric acid, phosphorus, calcium, potassium (tumor lysis panel)
  • Coagulation studies (DIC screen — up to 40% of patients with hyperleukocytosis develop DIC)
• Hyperleukocytosis (WBC > 100,000):
  • All of the above PLUS continuous monitoring, ICU admission
  • Avoid unnecessary RBC transfusion (increases blood viscosity and may worsen leukostasis symptoms)
• Drug-induced: Review medication list — corticosteroids are the most common cause of drug-induced leukocytosis in the ED; onset within hours of administration

Common ED Pitfall

• Steroid-induced leukocytosis: A single dose of dexamethasone (e.g. for croup, asthma, pharyngitis) can elevate WBC by 2,000–5,000/μL within 4–8 hours via neutrophil demargination; this does NOT indicate infection and should not prompt unnecessary antibiotic therapy

Management

• Directed at the underlying cause — leukocytosis itself rarely requires specific treatment
• Infection: Appropriate antibiotics/antivirals/antifungals based on suspected source
• Drug-induced: Discontinue or adjust offending agent if clinically appropriate
• Leukostasis / hyperleukocytosis (oncologic emergency):
  • Emergent hematology/oncology consultation
  • Aggressive IV hydration (target UOP > 2 mL/kg/hr) to prevent/treat tumor lysis syndrome
  • Tumor lysis prophylaxis: Allopurinol or rasburicase (do NOT alkalinize urine if using rasburicase)
  • Hydroxyurea (50–100 mg/kg/day) — cytoreductive therapy that can be initiated prior to identifying leukemia subtype
  • Leukapheresis — controversial; may be considered as temporizing measure in symptomatic leukostasis; avoid in APL (acute promyelocytic leukemia)
  • Avoid RBC transfusion unless critical anemia — increases viscosity and can precipitate/worsen leukostasis
  • Monitor electrolytes, coagulation studies, and CBC every 4–6 hours
  • DIC management if present (see Disseminated Intravascular Coagulation)
• Suspected acute leukemia (blasts on smear):
  • Emergent hematology consultation even if WBC is not extremely elevated
  • Tumor lysis panel and prophylaxis
  • Evaluate for Tumor Lysis Syndrome, DIC, and Febrile Neutropenia (if neutropenic despite high total WBC — this can occur when blasts predominate but functional neutrophils are low)

Disposition

• Admit / ICU:
  • Hyperleukocytosis (WBC > 100,000/μL)
  • Symptomatic leukostasis (pulmonary or CNS involvement) — one-week mortality ~50% untreated
  • New blasts on peripheral smear (suspected acute leukemia)
  • Leukocytosis with sepsis, hemodynamic instability, or organ dysfunction
  • DIC or tumor lysis syndrome
• Admit (general floor):
  • Significant leukocytosis (> 25,000–30,000/μL) with unidentified source requiring inpatient workup
  • Infection requiring IV antibiotics
  • New unexplained cytopenias alongside leukocytosis (pancytopenia with elevated WBC may indicate marrow pathology)
• Discharge with follow-up:
  • Mild leukocytosis (11,000–20,000/μL) with identified and treated cause (e.g. UTI, cellulitis, steroid-induced)
  • Asymptomatic, well-appearing patient with known chronic mild leukocytosis (e.g. smoking, obesity, chronic steroid use)
  • Ensure repeat CBC with differential within 1–2 weeks if new finding and no clearly identified cause
  • Refer to hematology if: persistent unexplained leukocytosis, WBC > 30,000/μL without reactive cause, concurrent cytopenias, abnormal peripheral smear, or concern for malignancy
• Poison control: Consider consultation if drug-induced or toxicologic cause suspected (1-800-222-1222)

See Also

• Eosinophilia
• Leukemia
• Febrile Neutropenia
• Tumor Lysis Syndrome
• Disseminated Intravascular Coagulation
• CBC
• Peripheral blood smear
• Sepsis
• Leukopenia
• Pancytopenia
• Lymphadenopathy

External Links

• Leukocytosis - StatPearls
• Evaluation of Patients with Leukocytosis - Am Fam Physician 2015
• Hyperleukocytosis and Leukostasis - ACEP Critical Care Section 2025